Clinical Trials Logo

Down Syndrome, Trisomy 21 clinical trials

View clinical trials related to Down Syndrome, Trisomy 21.

Filter by:
  • None
  • Page 1

NCT ID: NCT03687619 Completed - Clinical trials for Down Syndrome, Trisomy 21

Cognitive Orientation to Daily Occupational Performance and Conductive Education Approaches on Down Syndrome

Start date: March 5, 2019
Phase: N/A
Study type: Interventional

This study will be conducted to investigate and compare the effects of Cognitive Orientation to Daily Occupational Performance (CO-OP) and Conductive Education (CE) on fine motor skills, activity, and participation limitations in children with DS. Children with DS aged 7-18 years will be included. Both CO-OP and CE interventions will last 12 weeks and be conducted for 2 sessions per week in the cross-over randomized study. Following 12-week wash-out period, interventions will be changed for each group.

NCT ID: NCT03653143 Completed - Clinical trials for Down Syndrome, Trisomy 21

JASPER Intervention in Down Syndrome

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

The goal of this study is to determine whether JASPER (Joint Attention, Symbolic Play, Engagement, Regulation), which is an intensive, targeted early behavioral intervention focused on a developmentally based approach for teaching joint engagement, joint attention, and play skills can improve behavioral / emotional regulation, social communication skills, and developmental trajectories in Down syndrome (DS). The investigators will also explore the potential use of EEG and event-related potentials (ERP) as outcome measures, as this approach may help elucidate mechanisms of change in behavior and development, and may help explain differences in development of social communication skills in individuals with DS. EEG and ERP measure may also help to predict treatment outcome.

NCT ID: NCT00891852 Recruiting - Clinical trials for Down Syndrome (Trisomy 21)

Non-Invasive Determination of Fetal Chromosome Abnormalities

Start date: January 2009
Phase: N/A
Study type: Observational

The overall significance of this study is to develop a laboratory developed test (LDT) to use a new marker in the maternal blood to better identify pregnancies that have a child with a chromosome abnormality such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome, (47, XXY), and other chromosome abnormalities. Accomplishing that task would reduce the need for invasive amniocentesis and CVS procedures.

NCT ID: NCT00770458 Completed - Turner Syndrome Clinical Trials

Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

Start date: June 2008
Phase: N/A
Study type: Observational

Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.